Stay updated on Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial page.

Latest updates to the Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedLocations section now includes Wisconsin as a study site. The HHS Vulnerability Disclosure link was removed from the footer, and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no visible changes to the study details.SummaryDifference0.1%

- Check49 days agoChange DetectedThe government funding lapse notice on the page has been removed; this is a minor operational update that does not alter study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedNo significant changes detected between the old and new screenshots; the Study Details page, including eligibility criteria and contact information, remains consistent.SummaryDifference0.5%

- Check78 days agoChange DetectedUpdates to dates, protocol identifiers, and a refined misuse criteria; older version block removed. Overall, a modest content refresh with newer timestamps.SummaryDifference3%

- Check92 days agoChange DetectedAdded a government operations notice and a version update to v3.2.0; removed the previous v3.1.0 version reference.SummaryDifference3%

Stay in the know with updates to Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Effects of Psilocybin & Buprenorphine Formulation Clinical Trial page.